share_log

Covetrus Launches New Platform Application to Drive Proactive Prescription Management

Covetrus Launches New Platform Application to Drive Proactive Prescription Management

Covetrus推出新的平台應用程序以推動主動處方管理
道琼斯 ·  2020/01/16 21:00

Press Release: Covetrus Launches New Platform Application to Drive Proactive Prescription Management

新聞稿:Covetrus推出新的平台應用程序以推動主動處方管理

Covetrus Launches New Platform Application to Drive Proactive Prescription Management

Covetrus推出新的平台應用程序以推動主動處方管理

Covetrus Script Assist helps veterinarians enhance patient compliance

Covetrus腳本輔助幫助獸醫提高患者依從性


PORTLAND, Maine--(BUSINESS WIRE)--January 16, 2020--

緬因州波特蘭--(美國商業新聞網)--2020年1月16日--

Covetrus(TM) (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the availability of Covetrus Script Assist, a new and more convenient way for veterinarians to leverage practice management system information to more proactively prescribe preventative medications for patients with past or upcoming appointments.

亞洲網加利福尼亞州聖何塞2月28日電動物保健技術和服務的全球領先企業Covetrus(TM)(納斯達克市場代碼:CVeT)今天宣佈推出Covetrus Script Assistate,這是一種新的、更方便的方式,使獸醫可以利用實踐管理系統信息,更主動地為過去或即將預約的患者開預防性藥物。

Covetrus Script Assist leverages machine learning and practice management records to quickly identify where gaps in medical care reside, particularly in areas like preventative medications. Once a prescription is "created," the veterinarian or delegate will have minimal steps in order to get a prescription to the client for fulfillment on their storefront.

Covetrus Script Assist利用機器學習和實踐管理記錄來快速識別醫療保健方面的差距,特別是在預防性藥物等領域。一旦處方被“創建”,獸醫或代理人將只需最少的步驟就可以將處方送到客户那裏,以便在他們的店面上實現。

"Veterinarians continue to face challenges balancing the on-demand needs of today's consumer with the focus on delivering outstanding clinical care," said Georgia Wraight, executive vice present and president, Covetrus Global Technology Solutions. "Covetrus Script Assist is a great addition to our proactive prescription management capabilities and will be instrumental in helping veterinarians drive better clinical outcomes."

Covetrus全球技術解決方案公司執行副總裁兼總裁喬治亞·懷特説:“獸醫們繼續面臨着在平衡當今消費者的按需需求和專注於提供出色的臨牀護理之間取得平衡的挑戰。Covetrus Script Assistate是對我們主動處方管理能力的極大補充,將有助於幫助獸醫取得更好的臨牀結果。“

Signature features of Covetrus Script Assist include:

Covetrus Script Assist的簽名功能包括:


-- Systematic prescribing of preventatives - Veterinarians can proactively
prescribe preventatives for patients with past or upcoming appointments
that have not purchased any product within the last 18 months.

-- Reduced steps for issuing prescriptions - Once a proactive prescription
has been "created" the veterinarian or delegate will have just a few
steps in order to get a prescription to the client for fulfillment on
their storefront.

-- More informed compliance monitoring - The ability to quickly prescribe
preventatives will drive practices closer to compliance and keep their
patients healthy.

--系統地開出預防藥方--獸醫可以主動為過去或即將就診的患者開預防藥物在過去18個月內沒有購買任何產品。-減少開具處方的步驟-一次主動開出處方已被“創造”的獸醫或代表將只有幾個為客户開具處方以在以下時間履行的步驟他們的店面。--更有見地的合規監控--能夠快速開具處方預防措施將推動實踐更接近合規,並保持其病人身體健康。

"Script Assist has simplified our prescribing process and improved our workflow," said Lenore Corazza, CCFP, practice manager, Lake Austin Blvd Animal Hospital. "Setting up patients with automatic renewals leads to improved medication adherence. Covetrus is helping us to better communicate and strengthen the trust and confidence our clients have in us."

“腳本輔助簡化了我們的處方過程,改進了我們的工作流程,”CCFP的實踐經理Lenore Corazza説,她是奧斯汀大道動物醫院的業務經理。為患者設置自動續費可以提高服藥依從性。Covetrus正在幫助我們更好地溝通,並加強我們客户對我們的信任和信心。“

All Covetrus prescription management customers have access to the Script Assist application and may opt-in to use it. For those interested in learning more about Covetrus Script Assist, visit http://bit.ly/CVETSA. Covetrus will demo Script Assist at the annual VMX Veterinary Meeting & Expo from January 18-22 at booth #1101.

所有Covetrus處方藥管理客户都可以訪問腳本輔助應用程序,並可以選擇使用它。如果您有興趣瞭解更多關於Covetrus Script Assist的信息,請訪問http://bit.ly/CVETSA.Covetrus將在1月18日至22日在#1101展位舉行的一年一度的VMX獸醫會議和博覽會上演示腳本協助。

About Covetrus

關於Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. For more information about Covetrus visit https://www.covetrus.com/.

Covetrus是一家全球動物健康技術和服務公司,致力於增強獸醫實踐合作伙伴的能力,以推動改善健康和財務結果。我們將產品、服務和技術整合到一個平台中,將我們的客户與他們最佳工作所需的解決方案和洞察力連接起來。我們對動物福祉和那些關心它們的人的熱情驅使我們推動獸醫世界的發展。Covetrus總部設在緬因州波特蘭,擁有5500多名員工,為全球10萬多家客户提供服務。欲瞭解更多關於Covetrus的信息,請訪問https://www.covetrus.com/.。

Forward-Looking Statements

前瞻性陳述

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

本新聞稿包含符合1933年證券法(修訂本)第27A節和1934年證券交易法(修訂本)第21E節含義的前瞻性陳述,涉及風險和不確定性,包括有關我們的計劃、目標、預期和意圖的陳述。這樣的陳述會受到許多風險和不確定性的影響。可能對我們的業務和前景產生不利影響的因素在我們提交給證券交易委員會的公開文件中列出。我們的前瞻性陳述是基於我們管理團隊目前的信念和期望,除非法律要求,否則我們沒有義務對本新聞稿中包含的前瞻性陳述進行任何修改或更新,以反映本新聞稿發佈之日之後發生的事件或情況,無論是由於新信息、未來發展還是其他原因。告誡投資者不要過度依賴這些前瞻性陳述。

View source version on businesswire.com: https://www.businesswire.com/news/home/20200116005431/en/

在business wire.com上查看源代碼版本:https://www.businesswire.com/news/home/20200116005431/en/



CONTACT: Nicholas Jansen

聯繫人:尼古拉斯·詹森(Nicholas Jansen)

Investor Relations

投資者關係

207-550-8106

207-550-8106

nicholas.jansen@covetrus.com

郵箱:nicholas.jansen@covetrus.com

Kiní Schoop

基尼·斯庫普

Public Relations

公共關係

207-550-8018

207-550-8018

kini.schoop@covetrus.com

郵箱:kini.Schoop@covetrus.com




(END) Dow Jones Newswires

(完)道瓊通訊社

January 16, 2020 08:00 ET (13:00 GMT)

2020年1月16日東部時間08:00(格林尼治標準時間13:00)

*DJ Covetrus Launches New Platform Application to Drive Proactive Prescription Management

*DJ Covetrus推出新的平台應用程序,以推動主動處方管理



(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)

(更多信息)道瓊斯通訊社(212-416-2800)

January 16, 2020 08:00 ET (13:00 GMT)

2020年1月16日東部時間08:00(格林尼治標準時間13:00)

Copyright (c) 2020 Dow Jones & Company, Inc.

版權所有(C)2020道瓊斯公司。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論